Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Preleukemia × lintuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Hematologic Diseases 3 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Preleukemia 1 Myeloproliferative Disorders 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

venetoclax 1 spartalizumab 1 sabatolimab 1 ruxolitinib 1 lintuzumab 1 filanesib 1 Lenalidomide 1 Decitabine 1 CPI-0610 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00502112 2011-10-12

A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)

Seagen Inc.

Phase 1 Completed

MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡